Introduction {#Sec1}
============

The association of stem-cell factor (SCF, steel factor) with its receptor c-Kit (CD-117, Kit) mediates signaling that is critical for melanocyte survival, proliferation, differentiation, and migration (Alexeev and Yoon [@CR2]; Halaban [@CR10]; Wehrle-Haller [@CR35]). The binding of SCF to c-Kit induces autophosphorylation on tyrosines in the COOH-terminus of c-Kit, which activates its kinase (Mol et al. [@CR22]; Roskoski [@CR29]). In connection with cell survival, c-Kit activates multiple downstream signaling pathways, including the Ras/Raf/mitogen-activated protein kinase kinase (MAPKK)/mitogen-activated protein kinase (MAPK) pathway and the phosphatidylinositol 3-kinase (PI3K)/protein kinase B (AKT) pathway (Hemesath et al. [@CR11]; Roskoski [@CR29]). Furthermore, the over-expression or mutation of c-Kit has been observed in many human solid tumors (Hirota et al. [@CR13]). Consequently, c-Kit has been extensively studied as a target in anticancer drug development and as a key protein in melanogenesis (Attoub et al. [@CR4]; Kato et al. [@CR18]).

Studies with transgenic mice that carried SCF under the keratin promoter showed that SCF promoted the migration of melanocytes out of niches. When these mice were treated with a c-Kit antibody (ACK2), their progeny had white (unpigmented) skin and hair (Nishimura et al. [@CR25]). Interestingly, a few reports have shown that patients treated with imatinib (Gleevec) exhibited onset of hypopigmentation (Brazzelli et al. [@CR5]; Tsao et al. [@CR34]).

Melanogenesis is generally up-regulated by ultraviolet (UV) light. UV light exerts its effects directly on melanocytes or keratinocyte-derived factors (Hirobe [@CR12]). SCF/c-Kit signaling also plays a key role in the early phase of melanocyte activation during UVB-induced pigmentation (Hachiya et al. [@CR9]; Hosaka et al. [@CR14]; Tobiishi et al. [@CR33]). Exposure to UV or treatment with SCF increases the number of melanocytes in the dermis, mainly through the c-Kit-mediated signaling cascade (Kawaguchi et al. [@CR19]). Once activated, c-Kit phosphorylates the microphthalmia-associated transcription factor (MITF) via mitogen-activated protein kinase (MAPK); subsequently, the phosphorylated MITF promotes melanocyte maturation (Hemesath et al. [@CR11]; Tachibana [@CR32]). Therefore, blocking c-Kit signaling can radically prevent pigment formation through inhibition of both melanoblast differentiation and melanogenesis, rather than simply by inhibiting tyrosinase transcription.

Several small molecules have been developed or documented as whitening agents, including hydroquinone, kojic acid, arbutin, ascorbic acid, and retinoic acid. Currently, most whitening agents used in both the cosmetic and medical markets inhibit the activity of tyrosinase (Briganti et al. [@CR6]).

Recently, we isolated emodin as a suppressor of c-Kit signaling by screening a synthetic library based on naturally occurring compounds (Lee et al. [@CR21]). Here, we screened 2,000 plant extracts for c-Kit inhibitory activity and isolated anti-melanogenic flavonoids. Flavonoids are natural polyphenolic compounds that are reported to have anti-oxidative and kinase-inhibitory effects. For example, the flavonoids, quercetin, luteolin, and genistein, were shown to inhibit the kinase activities of epithelial growth factor receptor (EGFR), protein kinase C (PKC), and focal adhesion kinase (FAK) (Agullo et al. [@CR1]; Huang et al. [@CR15]; Kandaswami et al. [@CR17]). Several recent reports have also described the diverse effects that flavonoids have on melanogenesis in human skin and other cell lines (An et al. [@CR3]; Nagata et al. [@CR24]; Ohguchi et al. [@CR26]), however, the mechanism of action for c-Kit is unclear. In this study, we investigated whether flavonoids from *Chrysanthemum morifolium* might suppress melanogenesis through specific effects on c-Kit.

Materials and methods {#Sec2}
=====================

Materials {#Sec3}
---------

All the chemicals, except those specifically mentioned, were purchased from either CalBiochem (CA, USA) or Sigma Co. Ltd (MO, USA). The intracellular domain of the c-Kit protein was obtained from ProQinase (Germany). Kinase substrates were purchased from PerkinElmer (MA, USA) and anti-c-Kit antibody (pY719 and total-c-Kit) were obtained from Cell Signaling (MA, USA). The platelet-derived growth factor receptor (PDGFR) tyrosine kinase inhibitor III, 4-(6,7-dimethoxy-4-quinazolinyl)-*N*-(4-phenoxy phenyl)-1-piperazinecarboxamide, (521232, CalBiochem, CA) was used as a reference c-Kit inhibitor.

In vitro time-resolved fluorescence (TRF) kinase assay {#Sec4}
------------------------------------------------------

The inhibition of c-Kit (*N*-terminal GST-tagged recombinant human Kit, amino acid T544-V976 expressed by baculovirus system in *Sf*9 insect cells, ProQinase) was determined in a TRF assay. Briefly, c-Kit (20 ng/well) was incubated for 30 min at room temperature (RT) with 1.5 µM of peptide substrate (Biotin-VEEEAPEDLYKDFLTLEH, synthesized in Peptron, Daejeon, Korea), 10 μM ATP, and compounds to be tested for inhibition in a buffer containing 50 mM Tris (pH 7.5), 5 mM MgCl~2~, 5 mM MnCl~2~, 2 mM DTT, and 0.01 % Tween-20. The reaction mixture was transferred into a streptavidin-coated DELFIA 96-well plate (PerkinElmer) and incubated for 1 h. After washing 3 times with PBS/T (pH 7.0), the plates were further incubated with anti-phosphotyrosine (p-Y-100) antibody for 1 h and with Europium-labeled secondary anti-mouse antibody for 30 min; then the plate was rinsed again three times with PBS/T. Finally, Europium Enhancement Solution (PerkinElmer) was applied, and the TRF signal was measured in a Victor2 microplate reader (PerkinElmer). All experiments were performed in duplicate. IC~50~ values were obtained from a nonlinear regression analysis with GraphPad Prism version 5.0 for Windows (GraphPad Software, San Diego, CA).

AlphaBead kinase assay {#Sec5}
----------------------

Kinase activity was also determined using AlphaScreen™ phosphotyrosine (P-Tyr-100) assay kit (PerkinElmer, CT, USA). ALPHA (Amplified Luminescent Proximity Homogeneous Assay) is a bead-based immunoassay monitoring the energy transfer from streptavidin-coated donor bead to anti-phosphotyrosine antibody conjugated acceptor bead. The kinase assay was performed according to the protocol provided by the manufacturer. Briefly, kinase (5 μL, 2.5--10 ng) was incubated with 5 μL of kinase reaction buffer (50 mM Tris--HCl (pH 7.5), 5 mM MgCl~2~, 5 mM MnCl~2~, 2 mM DTT and 0.01 % Tween-20) containing a compound to be tested in a 384-well plate for 15 min at RT. Then, 5 μL of the reaction buffer containing biotinylated poly\[Glu:Tyr\](4:1) substrate (final conc. 5 nM) and ATP (final conc. 10 μM) were added and allowed to stand at RT for 1 h. The reaction was quenched by the addition of the capture buffer containing EDTA 100 mM, NaCl 250 mM, 62.5 mM HEPES, donor-streptavidin and acceptor P-Tyr-100 beads (final conc. 20 μM). After 1 h incubation at RT, AlphaScreen signal was detected in Fusion™ microplate analyzer (PerkinElmer). All the assays were performed in white 384-well plates (Greiner Bio-One, Germany) in a final volume of 25 μL.

Cell culture {#Sec6}
------------

All mammalian cells were grown in an appropriate culture media containing antibiotics (100 U/mL penicillin and 100 μg/mL streptomycin) in a humidified incubator under 5 % CO~2~ at 37 °C. MO7e cells (M-07 human megakaryocytic leukemia cell line) were generously provided by Dr. Young-Hee Lee (Chung-buk National University, Chungju, Korea). Primary melanocytes were obtained from circumcised tissue from a newborn baby. NCCmelan5 cells (mouse melanocyte cell line) were kindly donated by Dr. Mizoguchi and Yoko Kawa (St. Marianna University, Japan (Ooka et al. [@CR27])). MO7e cells were routinely propagated in Iscove's Modified Dulbecco's Medium (GIBCO, CA, USA), supplemented with heat-inactivated 10 % FBS and 1 ng/mL granulocyte macrophage colony stimulating factor (GM-CSF). NCCmelan5 cells were grown in Eagle's minimum essential medium (EMEM; GIBCO) supplemented with 15 % FBS, 50 ng/mL murine stem cell factor (mSCF; CHEMICON), and 100 nM endothelin 3 (EDN3). SK-mel2 cells were cultured in RPMI media supplemented with 10 % heat-inactivated FBS. Human primary melanocytes were maintained in MCDB153 media (Sigma, MO, USA) supplemented with 1 % FBS, 10 ng/mL phorbol 12-myristate 13-acetate (TPA), 5 μg/mL insulin, 0.5 μg/mL hydrocortisone, 1 ng/mL basic fibroblast growth factor (bFGF), 10 nM alpha-melanocyte stimulating hormone (α-MSH), and 1 μg/mL transferrin.

Western blot analysis {#Sec7}
---------------------

For Western blot analysis, cells were seeded at 70 % confluence in 6-cm dishes and deprived of cytokines in media supplemented with 1 % FBS for about 16 h. Subsequently, the test compounds were added for 45 min. Then the cells were stimulated with 50 ng/mL SCF for 10 min. To prepare the whole cell lysates, cells were washed twice with PBS and lysed. Then, cell lysates were electrophoretically separated on a 6 % SDS--polyacrylamide gel. Proteins were transferred onto Immobilon P-PVDF membranes (polyvinylidene fluoride, Millipore, MA, USA) overnight at 4 °C. Membranes were blocked with TBS containing 5 % skim milk and 0.1 % Tween 20, pH 7.4 for 1 h and then incubated sequentially with primary and secondary antibodies diluted in blocking buffer. Protein bands were detected with an enhanced chemiluminescence detection system (Cell Signaling, MA, USA) on a LAS-3000 (Fuji, Japan).

Isolation of diosmetin from *C. morifolium* {#Sec8}
-------------------------------------------

The air-dried flowers of *C. morifolium* were treated with 100 % methanol using the reflux method. The resulting methanol extract of *C. morifolium* was successively fractionated with *n*-hexane, chloroform, and *n*-butanol. Then, the *n*-butanol fraction of *C. morifolium* was separated by silica gel column chromatography with chloroform--methanol (20:1 \~ 2:1) to yield ten fractions. Effective fractions were purified by preparative HPLC (MERCK/SEPTECH) using a reverse phase column (CombiHT SB-18, 5 μm, 21.2 mm × 150 mm) and acetonitrile (35 \~ 50 %) to yield four fractions Y1, Y2, Y3 and Y4, which were identified as acacetin, diosmetin, apigenin, and luteolin, respectively, by comparing NMR spectroscopic data with the previously reported ones (Cai et al. [@CR7]; Christophoridou et al. [@CR8]; Kraus et al. [@CR20]; Seijas et al. [@CR30])

MTT and \[^3^H\]-thymidine incorporation assays {#Sec9}
-----------------------------------------------

Cytotoxic effects were evaluated with a MTT (3-\[4,5-dimethylthiazol-2-yl\]-2,5-diphenyltetrazolium bromide; thiazolyl blue) viability assay. The MTT assay is a standard colorimetric assay that measures the activity of enzymes that reduce MTT to insoluble purple formazan crystals. Cells were seeded on 96-well plates at a density of 1 × 10^4^ cells per well and treated with the test compounds at various concentrations for 48 h. Ten microliters of 5 mg/mL MTT solution was added and cells were incubated for 1 h. The medium was aspirated and 100 μL of DMSO was added to each well. After 10 min of incubation, the absorbance was measured at 570 nm.

Changes in cell proliferation were measured with a \[^3^H\]-thymidine incorporation assay. Cells were seeded at a density of 5 × 10^3^ cells per well on a 96-well plate. The next day, cells were pre-incubated with the test compounds for 1 h and then stimulated with SCF (100 ng/mL) for another 6 h. \[^3^H\]-Thymidine was added at 0.05 μCi per well and cells were further incubated for 48 h. After the cells were rinsed three times with PBS, a scintillation cocktail was added. Incorporated radioactive thymidine was counted on a MicroBeta scintillation counter (PerkinElmer).

\[^14^C\]-tyrosine incorporation assay {#Sec10}
--------------------------------------

Melanin content was assessed with radioactive tyrosine. Melanocytes were seeded on 96-well plates at a density of 1 × 10^4^ cells per well. The cells were allowed to stabilize for 24 h, then they were treated with the test compounds for 1 h, and then stimulated with 100 ng/mL of SCF or 30 mJ of UVB (312 nm) with a BIO-SUN irradiator (Vilber Lourmat, France). \[^14^C\]-tyrosine (Amersham Pharmacia Biotech, England) was added at 0.03 μCi per well and cells were incubated for 48 h. After the cells were washed with PBS three times, the radioisotope taken up by the cells was measured in a MicroBeta (PerkinElmer).

DOPA assay {#Sec11}
----------

Pigments synthesized from [l]{.smallcaps}-dihydroxyphenyl-alanine (DOPA) were visualized after DOPA supplementation. Melanocytes were serum-starved for 18 h; then, they were either irradiated with 30 mJ UVB or treated with SCF (100 ng/mL). Cells were incubated with the test compound or the reference compound for 48 h. After the medium was exchanged with serum-free media, cells were treated with 10 mM DOPA (Sigma Chemicals Co.) for 3 h at 37 °C. After removing the cell media, crystal mount was dropped on top of the cells and subsequently, cells were dried at 50 °C. Photos were taken in an inverted microscope (40× or 100×). The melanin content (total intensity ±S.D.) in each photo was analyzed with the image program MetaMorph^®^ (Molecular Devices).

MelanoDerm assay {#Sec12}
----------------

MelanoDerm™ (MEL-300-A-LLMM, MatTek, USA) is a human three-dimensional tissue model. This tissue model was used to test the effect of diosmetin against SCF. Melanoderm tissue was transferred into a 6-well plate with a cell culture insert atop a culture stand (MEL-STND). The culture medium contained pre-warmed EPI-100-LLMM (0.9 mL) and was placed below the cell insert to feed the basolateral side of the cells; 100 μl of PBS was placed on top of the cell inserts. EPI-100-LLMM (MatTak) is a commercial DMEM-based medium that contains α-MSH, bFGF, EGFR, insulin, hydrocortisone, and other proprietary stimulators of epidermal differentiation. Cells were incubated in SCF (200 ng/mL) for three days; then, compounds were applied for 2 more weeks. Fresh medium (5 mL) was applied to the basolateral side of the tissue every other day. Melanoderms were fixed with 10 % formalin and photos were taken from the top-view with a phase contrast microscope at 100× magnification.

Results {#Sec13}
=======

Inhibition of c-Kit phosphorylation by *C. morifolium* {#Sec14}
------------------------------------------------------

In search of c-Kit inhibitors, we evaluated 2,000 plant extracts with an enzymatic c-Kit assay. Twenty-one plant extracts showed \>70 % inhibition of c-Kit phosphorylation in vitro (data not shown). These 21 plant extracts were tested to determine whether they could block SCF-induced cellular c-Kit activation in megakaryocytic leukemia (MO7e) cells. Cells were pretreated with the indicated natural extracts and then treated with SCF. Phosphorylated c-Kit (pY719) was assessed in cells treated with or without SCF (Fig. [1](#Fig1){ref-type="fig"}). Downstream from c-Kit phosphorylation, extracellular signal-regulated kinase (ERK) responded consistently (data not shown). At the initial test concentration (30 ppm), only two extracts (serial numbers 13 and 16; *C. morifolium* and *Panax japonicus*) showed significant inhibition of c-Kit phosphorylation. The *C. morifolium* extract was selected for further purification because it showed the most potent dose-dependent inhibition of cell-based c-Kit phosphorylation in MO7e cells. Among the two fractions separated from the *C. morifolium* extract, the butanol layer (BL) exhibited higher inhibitory activity for c-Kit phosphorylation than the water layer. Therefore, the BL was submitted to chromatography with a silica gel column and then fractions were separated with preparative HPLC in reverse phase.Fig. 1Plant extracts were tested for inhibition of c-Kit phosphorylation in MO7e cells. **a** Twenty-one hit samples selected from a c-Kit enzyme assay were tested on MO7e cells. Cells were pre-treated with the indicated natural extracts for 45 min, and then treated with 50 ng/mL SCF for 10 min. In the immunoblot analysis, phosphorylated c-Kit was detected with anti-phospho (Y719) antibody. **b** The selected *C. morifolium* extract was further tested at the indicated concentrations. *R* is the reference inhibitor (521232, 10 μM)

*Chrysanthemum morifolium* extract suppressed SCF-/UVB-induced pigmentation {#Sec15}
---------------------------------------------------------------------------

Pigments like eumelanin and pheomelanin are synthesized from tyrosine and DOPA (Sugumaran [@CR31]). In our study, melanin synthesis was monitored by both tyrosine and DOPA incorporation assays. With exposure to 30 ppm of the BL fraction, SCF-induced melanin synthesis was completely blocked, and total synthesis was reduced by half (Fig. [2](#Fig2){ref-type="fig"}a, c). Furthermore, we tested whether the extract of *C. morifolium* could inhibit UVB-induced pigmentation since SCF/c-Kit signaling is activated in the early phase of melanogenesis during UVB irradiation. The increased pigment formation induced by UVB irradiation (30 mJ, a single dose) was also attenuated by treatment with the BL fraction at a concentration of 30 ppm in mouse melanocytes and human melanoma SK-mel2 cells (Fig. [2](#Fig2){ref-type="fig"}b, d).Fig. 2Anti-pigmentation effect of the BL from the *C. morifolium* extract. a \[^14^C\]-tyrosine incorporation was determined in NCCmelan5 cells after 48 h treatments with SCF (100 ng/mL). **b** \[^14^C\]-tyrosine incorporation was determined in NCCmelan5 cells 48 h after UVB-irradiation (30 mJ). **c** Representative data from DOPA assay after UVB-irradiation of NCCmelan5 cells. After exposure to SCF, cells were pretreated with the indicated concentrations of the BL and incubated for 48 h. The DOPA assay was performed, and the photos (×100) were taken with an inverted microscope. **d** DOPA assay in NCCmelan5 cells 18 h after stimulation with 30 mJ of UVB. Cells were incubated with the BL fraction for 48 h. After the medium was exchanged with serum-free media, the DOPA assay was performed and photos were taken at ×40 magnification. The *R* is the reference inhibitor (521232, 3 μM). The pigment areas of melanocytes were quantitated using program MetaMorph from three independent experiments (**c** & **d** *right panels*)

Identification of flavonoids from *C. morifolium* that inhibit c-Kit {#Sec16}
--------------------------------------------------------------------

All four of the compounds (Y1 \~ Y4) isolated from the BL fraction by HPLC showed effective inhibition of c-Kit phosphorylation in mouse melanocytes at 0.3 \~ 1.0 ppm (Fig. [3](#Fig3){ref-type="fig"}a). The separated compounds from the concentrated four fractions were identified as acacetin, diosmetin, apigenin, and luteolin by NMR and mass spectrometry analysis. Enzyme inhibitory activities of the isolated compounds were confirmed with AlphaBead kinase assay in vitro. In enzymatic assay, Luteolin demonstrated the strongest inhibitory potency and the other three showed moderate inhibition: IC~50~ = 1.0, 4.7, 12.1, and 13.3 μM for luteolin, apigenin, diosmetin, and acacetin, respectively (Fig. [3](#Fig3){ref-type="fig"}c). However, the cellular inhibitory potencies of the four flavonoids were determined to be diosmetin (0.8 μM) \> acacetin, apigenin (2.5 μM) \> luteolin (9.2 μM) in cultured NCCmelan5 cells (Fig. [3](#Fig3){ref-type="fig"}d). The first three active flavonoids based on cellular c-Kit inhibition were used in following studies with human melanocytes.Fig. 3Four compounds isolated from *C. morifolium* were tested for inhibition of c-Kit phosphorylation in mouse melanocytes. **a** Cells were pre-treated for 45 min with BL (0.3 ppm) and the four final fractions Y1 \~ Y4 separated from BL. Then, 50 ng/mL of SCF was added for 10 min. Phosphorylated c-Kit was detected with anti-phospho (Y719) antibodies. **b** The structures of four active compounds from fractions Y1 \~ Y4 purified from the BL of the *C. morifolium* extract. **c** c-Kit enzyme inhibition by acacetin, diosmetin, apigenin, and luteolin (AlphaBead assay). **d** Cell based c-Kit inhibition by the four purified compounds in NCCmelan5 cells. *R* is compound 521232 at 3 μM

SCF-induced proliferation of human melanocytes was suppressed by diosmetin, apigenin, and acacetin {#Sec17}
--------------------------------------------------------------------------------------------------

Cytotoxicity and anti-proliferative effects were determined with MTT and \[^3^H\]-thymidine incorporation assays. The three active flavonoids up to 10 μM did not affect cell viability within 48 h, but a reference compound, 521232, showed cytotoxicity at \>3 μM (Fig. [4](#Fig4){ref-type="fig"}a). When cells were treated with 100 ng/mL SCF, proliferation was accelerated about 2-fold compared to untreated cells. However, the SCF-stimulated proliferation was nearly blocked by pre-incubations with 3 μM of diosmetin, apigenin, and acacetin (Fig. [4](#Fig4){ref-type="fig"}b). Also, c-Kit inhibition experiment of the three flavonoids in human melanocytes gave similar results comparing to mouse melanocytes. Immunoblot analysis of c-Kit phosphorylation showed that diosmetin was the most potent c-Kit inhibitory flavonoid among these three compounds; at 1 μM concentration diosmetin almost removed the phosphorylated c-Kit band (Fig. [4](#Fig4){ref-type="fig"}c). Diosmetin, apigenin, and acacetin also significantly reduced ERK phosphorylation induced by SCF stimulation.Fig. 4The effect of flavonoids on SCF/c-Kit signaling in human melanocytes. **a** The influence of SCF and flavonoids on viability of human melanocytes was determined in 48 h. The MTT assay was performed as described in the "[Materials and Methods](#Sec2){ref-type="sec"}". **b** Proliferation of human melanocytes for 48 h was measured by \[^3^H\]-thymidine incorporation assay. **c** Representative immunoblot analysis of c-Kit and ERK after treatment with inhibitors. Compounds were pretreated at the indicated concentrations for 45 min and 50 ng/mL of SCF was applied for 10 min; then the Western blot was performed. For detection of c-kit phosphorylation, we used anti-phospho-c-Kit (p-Y-719), total-c-Kit, phospho-ERK (T202/Y204), or total-ERK antibodies. R is the compound 521232 at 3 μM; values are expressed as the mean values ±SD of three independent experiments

Inhibition of melanin synthesis by diosmetin in human melanocytes {#Sec18}
-----------------------------------------------------------------

Melanin synthesis of human melanocytes was induced either by SCF treatment or UV irradiation. SCF-stimulated melanin synthesis in human primary melanocytes was remarkably reduced by the addition of diosmetin, apigenin, or acacetin (Fig. [5](#Fig5){ref-type="fig"}a). In particular, diosmetin ≥3 μM) completely blocked SCF-induced \[^14^C\]-tyrosine incorporation; thus, tyrosine was only incorporated at normal (SCF non-treated) levels. Also, melanin synthesis induced by UVB irradiation was partially blocked by these active flavonoids (Fig. [5](#Fig5){ref-type="fig"}b). Diosmetin, apigenin and acacetin showed considerable suppression of the increased tyrosine-incorporation by UVB irradiation. Both the tyrosine and DOPA incorporation assays demonstrated consistent results for the inhibitory potency of diosmetin, reflecting the reduction of melanin content by diosmetin at ≥3 μM (Fig. [5](#Fig5){ref-type="fig"}c). The same pattern was observed in mouse melanocytes (data not shown).Fig. 5Anti-pigmentation effect of flavonoids on human melanocytes. \[^14^C\]-tyrosine incorporation was induced by 100 ng/mL SCF (**a**) or 30 mJ UVB (**b**) in human melanocytes. Cells were sequentially treated with 3 μM of compounds and 0.03 μCi of \[^14^C\]-tyrosine for 48 h, and then processed for analysis. **C**. The SCF-induced pigmentation was blocked by flavonoids in human melanocytes. Cells were pre-treated with compounds, then incubated with 100 ng/mL of SCF for 48 h. The photographs were taken under a microscope (×100)

Diosmetin showed effective anti-pigmentation activity in a human melanoderm model {#Sec19}
---------------------------------------------------------------------------------

Diosmetin suppressed basal melanin synthesis and SCF-induced pigmentation in the MelanoDerm™ system, a highly differentiated model of human epidermis that consisted of multilayered epidermal keratinocytes and melanocytes (Fig. [6](#Fig6){ref-type="fig"}). Diosmetin considerably lightened the tone of the dermis compared to untreated controls. Kojic acid (1 %), one of the most frequently used depigmentation agents, was applied as a positive control. The concentration of diosmetin and Kojic acid was determined from a preliminary experiment. Diosmetin 60 μM (equal to 0.018 %) showed effective prevention of SCF-induced melanogenesis in a MelanoDerm experiment performed for 2-weeks.Fig. 6MelanoDerm assay. After SCF (200 ng/mL) treatment for three days, diosmetin (60 μM) or kojic acid (1 %) was applied, and cells were incubated for two more weeks. Each melanoderm was fixed with 10 % formalin and photos were taken from the top-view with a phase contrast microscope at ×100 magnification

Discussion {#Sec20}
==========

SCF is an important factor that stimulates the proliferation and melanogenesis of melanocytes and mediates the pigmentation response to UV irradiation (Imokawa [@CR16]; Kawaguchi et al. [@CR19]). Blocking SCF/c-Kit signaling can reduce differentiation of melanoblasts and proliferation of melanocytes (Nishimura et al. [@CR25]). Furthermore, administration of small molecules that specifically inhibited c-Kit showed inhibition of melanogenesis in mice, brown guinea pigs, and human beings (Brazzelli et al. [@CR5]; Na et al. [@CR23]).

To date, tyrosinase has been a major target of whitening agents like hydroquinone and arbutin, but their whitening effects were insufficient and transient. Therefore, in this study, we attempted to discover more effective depigmentation agents by screening plant extracts for novel c-Kit inhibitors. The rational design of synthetic chemicals sometimes yields the most potent and selective inhibitors for therapeutic targets. However, plants and herbs provide invaluable sources in the development of novel medicines and novel scaffolds for therapeutic agents. Many compounds derived from herbs and plants are highly bioactive and merit development as drugs (Pieroni et al. [@CR28]). However, plant extracts typically contain high amounts of fluorescent phytochemicals. Therefore, homogeneous high-throughput screening methods like fluorescent resonance energy transfer (FRET) are improper due to the high background noise. In order to remove the difficulty of internal fluorescence, we adopted a TRF assay that used antibodies labeled with europium; Low backgrounds could be achieved because of the time-difference between excitation and emission fluorescence.

In this study, we found that the accelerated melanin synthesis and proliferation induced by SCF were reduced with the addition of diosmetin. This SCF-inhibitory effect was equivalent to that of the reference compound (521232). The results from the melanoderm tissue model implied that 60 μM diosmetin (0.0018 %) had higher efficacy than the reference inhibitor, kojic acid (1 %), without any toxicity. Furthermore, we assessed the allergenic potential of diosmetin with a local lymph node assay in BALB/C mice. The results showed that diosmetin did not induce an allergic response; Stimulus index (S.I.) were between 0.8 and 1.1 based on the isolated lymph cells from lymph node after 3-day treatment of 10, 20 and 30 % diosmetin (25 μL) on mice ears. In fact, diosmetin is already in use on the market as an anti-oxidative skin stress agent (Kaden Biochemicals GMBH, Germany); thus, its safety in one aspect has been previously approved.

In summary, diosmetin, isolated from a *C. morifolium* extract, showed dose-dependent inhibition of SCF-/UVB-induced pigmentation and c-Kit phosphorylation. In addition, diosmetin effectively blocked increases in proliferation and melanin synthesis induced by SCF in mouse and human cells. Investigations with mouse NCCmelan5 cells, human primary melanocytes, and MelanoDerm tissue showed diosmetin produced consistent anti-pigmentation effects. Therefore, as c-Kit inhibitors diosmetin and *C. morifolium* extracts could be potential candidates of effective whitening agents.
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